University of Puerto Rico, Comprehensive Cancer Center
San Juan, PR, 00926, Puerto Rico
NCT Number: NCT07214051
The United States Preventive Services Task Force (USPSTF) recommends regular screenings for breast, cervical, and colorectal cancer. The COVID-19 pandemic has disrupted health screening practices, leading to a decrease in cancer screenings among the United States including Puerto Rico. This has been attributed to unwillingness, distrust, and insecurity related to accessing healthcare services. To overcome these challenges, a collaboration between PR-CEAL's Community Outreach Engagement Group (COEG), academic researchers, healthcare institutions, and community-based organizations proposed to engage in different community activities throughout the island. In these events, investigators conducted a single blinded community-based Randomized Clinical Trial (RCT) regarding cancer screening practices in women 21 through 75 years. The community-based RCT employed a mixed-method design to gain insights into the perception of health and cancer screening status of participants regarding breast, uterine (cervical), and colorectal cancer. Data was collected through in person interviews and two follow up phone calls, enabling the researchers to obtain valuable sociodemographic information, assessing cancer screening history, and identifying existing barriers.
The hypothesis of this study is that implementing evidence-based intervention at community settings across Puerto Rico will have a significant positive effect on cancer screening rates among non-adherent patients. By identifying and adapting the Prevention Care Management for Cancer Screening intervention and leveraging the expertise of the National Cancer Institute, the study aimed to improve screening rates, address barriers that hinder or delay screenings, and raise awareness about the importance of early detection.
Looking for future studies?
Notify Me21 year–75 year
Female
Interventional
Not applicable
San Juan, PR, 00926, Puerto Rico
The study aimed to recruit 500 participants. Recruited participants were women aged 21 through 75 years, overdue in at least one cancer screening test (breast cancer, cervical cancer, and/or colorectal cancer) based on the US Preventive Services Task Force (USPSTF) guidelines. Once the woman verbally consents to participate in the RCT, four pre-screening questions and a Cancer Screening Module will be conducted to determine her eligibility. If the woman is eligible, informed consent will be completed, followed by a contact information module, and a baseline survey using an adaptation of the Prevention Care Management approach.
After identifying overdue participants and obtaining their RCT participation consent, REDcap randomly assigned them to control or intervention groups in a 1:1 ratio. The control group (n=250) received physical activity and mindfulness materials, while the intervention group (n=250) received educational materials that included screening center details and reminders related to cancer screening. Two follow-up calls, at four-week intervals, were performed to assess the screening status for all participants.
Once the study concluded, the control group received the cancer educational materials by mail.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention group (n=250) received educational materials that included: screening center details, and reminders related to cancer screening. Two follow-up calls, at four-week intervals each, assessed screening status for all participants.
Time frame: Eight weeks
Once recruited, participants have two follow-up calls at four-week intervals each to assess their cancer screening test status (i.e., whether they have had their mammograms, pap test, and FOBT or colonoscopy).
Time frame: Eight weeks
Once recruited, participants have two follow-up calls at four-week intervals each to assess the scheduling of an appointment for their cancer screening test.
University of Puerto Rico Comprehensive Cancer Center
Other
Acronym: PR-CEAL:COEG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03629717
Breast Cancer Prevention, Breast Diseases
St Louis, Missouri, United States
View Trial DetailsNCT02028221
Breast Cancer Prevention
Tucson, Arizona, United States
View Trial DetailsNCT01299623
Breast Cancer Prevention, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00668174
Breast Cancer Prevention
Seattle, Washington, United States
View Trial Details